118 related articles for article (PubMed ID: 24493285)
1. Nin one binding protein expression as a prognostic marker in prostate carcinoma.
Liu G; Shen D; Jiao L; Sun Y
Clin Transl Oncol; 2014 Sep; 16(9):843-7. PubMed ID: 24493285
[TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of the nin one binding protein and p38 MAPK in prostate carcinoma.
Che JP; Li W; Yan Y; Liu M; Wang GC; Li QY; Yang B; Yao XD; Zheng JH
Int J Clin Exp Pathol; 2013; 6(11):2300-11. PubMed ID: 24228091
[TBL] [Abstract][Full Text] [Related]
3. Positive nin one binding protein expression predicts poor outcome in prostate cancer.
Chen J; Wang J; Cui X; Liu Y; Yin L; Li Y; Chen L; Xu D; Gao Y
Mol Med Rep; 2015 Apr; 11(4):2671-6. PubMed ID: 25503472
[TBL] [Abstract][Full Text] [Related]
4. A three gene-based risk score predicts prognosis of resected non-small-cell lung cancer.
Liu K; Chen HL; Gu MM; You QS
Int J Clin Exp Pathol; 2015; 8(12):16081-8. PubMed ID: 26884885
[TBL] [Abstract][Full Text] [Related]
5. NOB1 expression predicts early response to cisplatin-based chemotherapy in patients with advanced non-small cell lung cancer.
Liu K; Chen HL; Gu MM; You QS
J Chemother; 2016 Jun; 28(3):225-9. PubMed ID: 25971309
[TBL] [Abstract][Full Text] [Related]
6. Relationship between NOB1 expression and prognosis of resected non-small cell lung cancer.
Liu K; Chen HL; Gu MM; You QS
Int J Biol Markers; 2015 Feb; 30(1):e43-8. PubMed ID: 25450647
[TBL] [Abstract][Full Text] [Related]
7. MiR-192 suppresses the tumorigenicity of prostate cancer cells by targeting and inhibiting nin one binding protein.
Sun J; Fan Z; Lu S; Yang J; Hao T; Huo Q
Int J Mol Med; 2016 Feb; 37(2):485-92. PubMed ID: 26743688
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of NOB1 expression in breast infiltrating ductal carcinoma.
Li XY; Luo QF; Li J; Wei CK; Kong XJ; Zhang JF; Fang L
Int J Clin Exp Pathol; 2013; 6(10):2137-44. PubMed ID: 24133592
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer.
Guo J; Wang M; Wang Z; Liu X
PLoS One; 2016; 11(8):e0158667. PubMed ID: 27537362
[TBL] [Abstract][Full Text] [Related]
10. NOB1 Gene as a Potential Biomarker in Clinical Outcomes and Prognosis of Patients with Gastric Cancer.
Qi H; Wang Y
Clin Lab; 2018 Sep; 64(9):1469-1475. PubMed ID: 30274015
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of NOB1 expression inhibits the malignant transformation of human prostate cancer cells.
Zhang X; Zhang D; Qu F; Hong Y; Cao J; Pan X; Li L; Huang Y; Huang H; Yin L; Chen L; Ren J; Wang Z; Xu D; Cui X
Mol Cell Biochem; 2014 Nov; 396(1-2):1-8. PubMed ID: 25169742
[TBL] [Abstract][Full Text] [Related]
12. Overexpressed Rce1 is positively correlated with tumor progression and predicts poor prognosis in prostate cancer.
Huang L; Li M; Wang D; He J; Wu W; Zeng Q; Li J; Xiao M; Hu J; He Y; Li Y; Mai L; Liu W
Hum Pathol; 2016 Jan; 47(1):109-14. PubMed ID: 26546252
[TBL] [Abstract][Full Text] [Related]
13. Prognostication of OCT4 isoform expression in prostate cancer.
de Resende MF; Chinen LT; Vieira S; Jampietro J; da Fonseca FP; Vassallo J; Campos LC; Guimarães GC; Soares FA; Rocha RM
Tumour Biol; 2013 Oct; 34(5):2665-73. PubMed ID: 23636800
[TBL] [Abstract][Full Text] [Related]
14. High Expression of RIOK2 and NOB1 Predict Human Non-small Cell Lung Cancer Outcomes.
Liu K; Chen HL; Wang S; Gu MM; Chen XM; Zhang SL; Yu KJ; You QS
Sci Rep; 2016 Jun; 6():28666. PubMed ID: 27346559
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
16. EXPRESSION MECHANISM AND CLINICAL SIGNIFICANCE OF NOB1 IN GASTRIC CANCER TISSUE AND ADJACENT NORMAL TISSUE.
Zhou WP; Liu X; Yang Y; Liu YF
J Biol Regul Homeost Agents; 2015; 29(2):423-30. PubMed ID: 26122232
[TBL] [Abstract][Full Text] [Related]
17. Role of tumor-associated macrophages in the Hexim1 and TGFβ/SMAD pathway, and their influence on progression of prostatic adenocarcinoma.
Ok Atılgan A; Özdemir BH; Akçay EY; Ataol Demirkan Ö; Tekindal MA; Özkardeş H
Pathol Res Pract; 2016 Feb; 212(2):83-92. PubMed ID: 26608417
[TBL] [Abstract][Full Text] [Related]
18. BAG3 protein delocalisation in prostate carcinoma.
Staibano S; Mascolo M; Di Benedetto M; Vecchione ML; Ilardi G; Di Lorenzo G; Autorino R; Salerno V; Morena A; Rocco A; Turco MC; Morelli E
Tumour Biol; 2010 Oct; 31(5):461-9. PubMed ID: 20535599
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis.
Serce NB; Boesl A; Klaman I; von Serényi S; Noetzel E; Press MF; Dimmler A; Hartmann A; Sehouli J; Knuechel R; Beckmann MW; Fasching PA; Dahl E
BMC Cancer; 2012 Dec; 12():597. PubMed ID: 23236990
[TBL] [Abstract][Full Text] [Related]
20. High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.
Shubbar E; Helou K; Kovács A; Nemes S; Hajizadeh S; Enerbäck C; Einbeigi Z
BMC Cancer; 2013 Feb; 13():47. PubMed ID: 23374458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]